Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia

• Harinder Gill,
• Cheuk-Him Man,
• Alvin H.W. Ip,
• William W.L. Choi,
• Howard C.H. Chow,
• Yok-Lam Kwong,
• Anskar Y.H. Leung

Affiliations

Harinder Gill

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China

Cheuk-Him Man

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China

Alvin H.W. Ip

Department of Pathology, the University of Hong Kong, China

William W.L. Choi

Department of Pathology, the University of Hong Kong, China

Howard C.H. Chow

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China

Yok-Lam Kwong

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China

Anskar Y.H. Leung

Division of Haematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, the University of Hong Kong, China